| Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies RH Advani, JJ Buggy, JP Sharman, SM Smith, TE Boyd, B Grant, ... Journal of Clinical Oncology 31 (1), 88-94, 2013 | 1442 | 2013 |
| Acalabrutinib (ACP-196) in relapsed chronic lymphocytic leukemia JC Byrd, B Harrington, S O’Brien, JA Jones, A Schuh, S Devereux, ... New England Journal of Medicine 374 (4), 323-332, 2016 | 1075 | 2016 |
| Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 SEM Herman, AL Gordon, E Hertlein, A Ramanunni, X Zhang, ... Blood, The Journal of the American Society of Hematology 117 (23), 6287-6296, 2011 | 1032 | 2011 |
| Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: an open-label, multicentre, phase 1b/2 trial S O'Brien, RR Furman, SE Coutre, JP Sharman, JA Burger, KA Blum, ... The lancet oncology 15 (1), 48-58, 2014 | 732 | 2014 |
| Acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia: results of the first randomized phase III trial JC Byrd, P Hillmen, P Ghia, AP Kater, A Chanan-Khan, RR Furman, ... Journal of clinical oncology 39 (31), 3441-3452, 2021 | 531 | 2021 |
| Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial M Wang, S Rule, PL Zinzani, A Goy, O Casasnovas, SD Smith, G Damaj, ... The Lancet 391 (10121), 659-667, 2018 | 473 | 2018 |
| Inhibition of Bruton tyrosine kinase in patients with severe COVID-19 M Roschewski, MS Lionakis, JP Sharman, J Roswarski, A Goy, ... Science immunology 5 (48), eabd0110, 2020 | 383 | 2020 |
| Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib FT Awan, A Schuh, JR Brown, RR Furman, JM Pagel, P Hillmen, ... Blood advances 3 (9), 1553-1562, 2019 | 216 | 2019 |
| Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results JC Byrd, WG Wierda, A Schuh, S Devereux, JM Chaves, JR Brown, ... Blood, The Journal of the American Society of Hematology 135 (15), 1204-1213, 2020 | 196 | 2020 |
| Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study RG Owen, H McCarthy, S Rule, S d'Sa, SK Thomas, O Tournilhac, ... The Lancet Haematology 7 (2), e112-e121, 2020 | 153 | 2020 |
| Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib C Sun, P Nierman, EK Kendall, J Cheung, M Gulrajani, SEM Herman, ... Blood, The Journal of the American Society of Hematology 136 (1), 93-105, 2020 | 101 | 2020 |
| Acalabrutinib in treatment-naive chronic lymphocytic leukemia JC Byrd, JA Woyach, RR Furman, P Martin, S O’Brien, JR Brown, ... Blood, The Journal of the American Society of Hematology 137 (24), 3327-3338, 2021 | 99 | 2021 |
| Hilfer fractional stochastic integro-differential equations HM Ahmed, MM El-Borai Applied Mathematics and computation 331, 182-189, 2018 | 99 | 2018 |
| Acalabrutinib plus obinutuzumab in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia JA Woyach, JS Blachly, KA Rogers, SA Bhat, M Jianfar, G Lozanski, ... Cancer discovery 10 (3), 394-405, 2020 | 86 | 2020 |
| Impulsive Hilfer fractional differential equations HM Ahmed, MM El-Borai, HM El-Owaidy, AS Ghanem Advances in Difference Equations 2018, 1-20, 2018 | 84 | 2018 |
| Optical solitons and other solutions to Kaup–Newell equation with Jacobi elliptic function expansion method HM Ahmed, WB Rabie, MA Ragusa Analysis and Mathematical Physics 11, 1-16, 2021 | 75 | 2021 |
| The Bruton's tyrosine kinase inhibitor, PCI-32765, is well tolerated and demonstrates promising clinical activity in chronic lymphocytic leukemia (CLL) and small lymphocytic … JA Burger, S O'Brien, N Fowler, R Advani, JP Sharman, RR Furman, ... Blood 116 (21), 57, 2010 | 75 | 2010 |
| Approximate controllability of impulsive neutral stochastic differentialequations with fractional Brownian motion in a Hilbert space HM Ahmed Advances in Difference Equations 2014, 1-11, 2014 | 74 | 2014 |
| The averaging principle of Hilfer fractional stochastic delay differential equations with Poisson jumps HM Ahmed, Q Zhu Applied Mathematics Letters 112, 106755, 2021 | 73 | 2021 |
| Topological and singular soliton solution to Kundu–Eckhaus equation with extended Kudryashov's method MM El-Borai, HM El-Owaidy, HM Ahmed, AH Arnous, S Moshokoa, ... Optik 128, 57-62, 2017 | 69 | 2017 |
